| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/26/2013 | US20130254935 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 09/26/2013 | US20130254933 Cry1i proteins and genes for insect control |
| 09/26/2013 | US20130254908 MO-1, A Gene Associated With Morbid Obesity |
| 09/26/2013 | US20130253382 Targeted enzymatic degradation of quorum-sensing peptides |
| 09/26/2013 | US20130253176 Host cells comprising alpha 1, 2 mannosidase and culture methods thereof |
| 09/26/2013 | US20130253171 Colour reduction in canola protein isolate |
| 09/26/2013 | US20130253170 Hyaluronic acid-protein conjugate and method for preparing same |
| 09/26/2013 | US20130253169 Peptide capable for binding to gold |
| 09/26/2013 | US20130253074 Implantation Material Comprising Biocompatible Polymer |
| 09/26/2013 | US20130253040 Methods and compositions for treating huntington's disease |
| 09/26/2013 | US20130252905 Plif multimeric peptides and uses thereof |
| 09/26/2013 | US20130252896 Tfpi inhibitors and methods of use |
| 09/26/2013 | US20130252895 Peptides of syndecan-1 for inhibit angiogenesis |
| 09/26/2013 | US20130252887 Compositions and methods for treating antiphospholipid syndrome |
| 09/26/2013 | US20130252884 Fgf21 analogues and derivatives |
| 09/26/2013 | US20130252306 Methods for increasing protein polyethylene glycol (peg) conjugation |
| 09/26/2013 | US20130252282 Optical control of protein activity and localization by fusion to photochromic protein domains |
| 09/26/2013 | US20130252260 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom |
| 09/26/2013 | US20130251821 Vegf-activated fas ligands |
| 09/26/2013 | US20130251744 Virus like particle composition |
| 09/26/2013 | US20130251740 Immunogenic agents |
| 09/26/2013 | US20130251739 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/26/2013 | US20130251738 Vaccines |
| 09/26/2013 | US20130251727 Egfr-based peptides |
| 09/26/2013 | US20130251720 Novel compositions and methods for the treatment of immune related diseases |
| 09/26/2013 | US20130251719 Bone marrow aplasia with haemorrhagic disease in calves caused by novel pathogen |
| 09/26/2013 | US20130251713 Methods for treating juvenile rhumatoid arthritis by administering a soluble ctla4 molecule |
| 09/26/2013 | US20130251712 Covalently dimerized bivalent binding agents |
| 09/26/2013 | US20130251681 Vesicular stomatitis viruses |
| 09/26/2013 | US20130251637 Fluorescent compounds |
| 09/25/2013 | EP2641911A2 Compositions and methods for re-programming cells without genetic modification |
| 09/25/2013 | EP2641608A2 Products and methods using soy peptides to lower total and LDL cholesterol levels |
| 09/25/2013 | EP2640842A1 Methods and compositions for inducing an immune response to egfrviii |
| 09/25/2013 | EP2640832A1 New ethiological agent |
| 09/25/2013 | EP2640751A1 Lipidated polyepitope vaccines |
| 09/25/2013 | EP2640741A1 Methods of treating fgf21-associated disorders |
| 09/25/2013 | EP2640740A1 Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3) |
| 09/25/2013 | EP2640739A2 Inhibitors of apoptosis and uses thereof |
| 09/25/2013 | EP2640738A1 Anti-fungal agents |
| 09/25/2013 | EP2640415A1 Cross protective epitopes of aspergillus fumigatus and candida albicans |
| 09/25/2013 | EP2640413A1 A process for reduction and/or removal of fxi and fxia from solutions containing said coagulation factors |
| 09/25/2013 | EP2640407A1 Method for increasing neprilysin expression and activity |
| 09/25/2013 | EP2640399A2 Methods and compositions for modulating pd1 |
| 09/25/2013 | EP2640182A1 Drought tolerant plants |
| 09/25/2013 | CN1918285B System and method of up-regulating bone morphogenetic protein (bmp) gene expression in bone cells via the application of fields generated by specific and selective electric and electromagnetic signal |
| 09/25/2013 | CN103328648A Peptide with safer secondary structure, peptide library, and production methods for same |
| 09/25/2013 | CN103328638A Densovirus-derived vector fir gene transfer in insects |
| 09/25/2013 | CN103328637A Novel bacillus thuringiensis genes with lepidopteran activity |
| 09/25/2013 | CN103328507A ALPHABODY libraries and methods for producing the same |
| 09/25/2013 | CN103328504A Delivery of a selectively replicating herpes simplex viral vector to the brain by convection- enhanced delivery (CED) |
| 09/25/2013 | CN103328503A Process for production of fibrinogen |
| 09/25/2013 | CN103328502A Methods of treating fgf21-associated disorders |
| 09/25/2013 | CN103328501A Novel biomarker and uses thereof in diagnosis, treatment of autism |
| 09/25/2013 | CN103328500A Methods and compounds for the diagnosis and treatment |
| 09/25/2013 | CN103328499A Immune-modulating agents and uses therefor |
| 09/25/2013 | CN103328498A Novel o-acetylhomoserine sulfhydrylase or variant thereof, and method for transforming methionine using same |
| 09/25/2013 | CN103328000A A process for reduction and/or removal of FXI and FXIa from solutions containing said coagulation factors |
| 09/25/2013 | CN103327987A Extract of aquatic animal cartilage |
| 09/25/2013 | CN103320485A Preparation method of fish-skin collagen for medical biomaterial |
| 09/25/2013 | CN103320461A Method for constitutive expression of target antibacterial peptide AgPlectasin in Pichia pastoris |
| 09/25/2013 | CN103320451A Genetic engineering protein vaccine for preventing EV71, and preparation method thereof |
| 09/25/2013 | CN103320449A Allium chinensis lectin gene with anti-tumor activity and application of coding protein thereof |
| 09/25/2013 | CN103320448A Lilium regle bZIP transcription factor LrbZIP1 and application |
| 09/25/2013 | CN103320446A Procambarus clarkia inhibin 1 gene as well as coded inhibin1 protein and application thereof |
| 09/25/2013 | CN103320370A Bacillus subtilis C3 and its anti-Listeria monocytogenes bacteriocin preparation method |
| 09/25/2013 | CN103319596A Compositions and methods for increasing bone mineralization |
| 09/25/2013 | CN103319593A Anti StxII monoclonal antibody |
| 09/25/2013 | CN103319591A Preparation of complete antigen and monoclonal antibody of gonyatoxine GTX2,3 |
| 09/25/2013 | CN103319590A Application of Chlamys farreri peptidoglycan recognition protein (CfPGRP-S1) |
| 09/25/2013 | CN103319589A Preparation method of bioactive peptide for inhibiting stomach cancer stem cell proliferation |
| 09/25/2013 | CN103319588A Method for extracting galectin-3 from ranid and preparation thereof |
| 09/25/2013 | CN103319587A Fish food intake promotion mature peptide and application thereof |
| 09/25/2013 | CN103319586A Antimicrobial peptide MP1102 of anti-drug resistance staphylococcus aureus and preparation method and application thereof |
| 09/25/2013 | CN103319585A Application of BC1 protein in adjusting and controlling crystallinity of plant cellulose |
| 09/25/2013 | CN103319584A Bruguiear gymnorrhiza (L.) Lam ERF transcription factor cDNA sequence, its expression vector and application |
| 09/25/2013 | CN103319583A Plant stress tolerance-associated protein TaNF-YB 1, coding genes thereof and applications |
| 09/25/2013 | CN103319582A Plant stress tolerance-associated protein TaNF-YA 1, coding genes thereof and applications |
| 09/25/2013 | CN103319581A Plant cold tolerance-associated protein LTT9, coding genes thereof and applications |
| 09/25/2013 | CN103319580A Plant stress tolerance-associated protein TaNHSF1, coding genes thereof and applications |
| 09/25/2013 | CN103319579A Protein AFLA-216 associated with azole drug sensitivity in aspergillus flavus as well as encoding gene and application thereof |
| 09/25/2013 | CN103319578A Gene affecting pathogenicity and generation of conidium and originated from cabbage fusarium wilt bacteria and application of same |
| 09/25/2013 | CN103319577A Haemophilus parasuis (Hps) immunoprotecive antigen OppA |
| 09/25/2013 | CN103319576A Haemophilus parasuis (Hps) immunoprotecive antigen AfuA |
| 09/25/2013 | CN103319575A Haemophilus parasuis (Hps) immunoprotecive antigen CdtB |
| 09/25/2013 | CN103319574A 分离的多肽及其应用 Isolated polypeptides and their Applications |
| 09/25/2013 | CN103319573A Method for producing classical swine fever virus subunit vaccine by utilizing bombyx mori bioreactor |
| 09/25/2013 | CN103319572A Hepatitis B surface antigen purification method |
| 09/25/2013 | CN102703467B Soybean drought-resistant zinc finger protein gene STF-2 |
| 09/25/2013 | CN102698260B Preparation method and application of subunit vaccine for preventing Staphylococcus-induced mammitis of goats |
| 09/25/2013 | CN102643829B Rice yield gene GY6 clone and application thereof |
| 09/25/2013 | CN102634472B Spore-free crystal-free bacterial strain of Bacillus thuringiensis as well as construction method and applications thereof |
| 09/25/2013 | CN102627696B Preparation method of phencyclidine artificial antigen |
| 09/25/2013 | CN102614506B Recombinant HPV16L2 protein vaccine and preparation method thereof |
| 09/25/2013 | CN102584973B Rice plant type related protein LPA1 and coding gene and application thereof |
| 09/25/2013 | CN102360008B Kit based on duck plague virus gG segmented recombinant protein and its application |
| 09/25/2013 | CN102276707B Pichia pastoris wall protein Gcw19 as well as surface display system and construction method thereof |
| 09/25/2013 | CN102276705B Pichia pastoris wall protein Gcw17, surface display system constructed by same and construction method of surface display system |
| 09/25/2013 | CN102276703B Pichia pastoris wall protein Gcw51, and surface display system and construction method thereof |
| 09/25/2013 | CN102276702B Pichia pastoris wall protein Gcw30 and surface display system and construction method thereof |
| 09/25/2013 | CN102260336B Pichia pastoris wall protein Gcw5, surface display system constructed by same and construction method of surface display system |